Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
We previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucida...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/8/4/97 |
_version_ | 1797710256766189568 |
---|---|
author | Ana Todorović Snežana Pejić Ljubica Gavrilović Ivan Pavlović Vesna Stojiljković Nataša Popović Snežana B. Pajović |
author_facet | Ana Todorović Snežana Pejić Ljubica Gavrilović Ivan Pavlović Vesna Stojiljković Nataša Popović Snežana B. Pajović |
author_sort | Ana Todorović |
collection | DOAJ |
description | We previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucidate the mechanism of the observed changes, we examined protein and mRNA levels of copper-zinc superoxide dismutase (CuZnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and transcription factor Nrf2. We also examined correlations of AOE expression with AOE activity, lipid hydroperoxides (LOOH) level, and level of Nrf2. Our results showed decreased CuZnSOD, CAT, and Nrf2 levels, and increased GPx and GR levels in hyperplasias, while in patients with adenocarcinoma, the level of CAT was decreased and GR was increased, compared to benign groups. Similar changes in mRNA levels were also detected, indicating predominantly translational control of the AOE expression. The positive correlation of enzyme expression/activity was recorded for CuZnSOD, GPx, and GR, but only among groups with benign diseases. Only GR and GPx expressions were positively correlated with LOOH. Nrf2 protein was positively correlated with mRNA levels of CuZnSOD and GR. Observed results indicate involvement of diverse redox mechanisms in etiopathogenesis of different gynecological diseases, and may improve redox-based approaches in current clinical practice. |
first_indexed | 2024-03-12T06:49:33Z |
format | Article |
id | doaj.art-b70b7a3abf1e46ecafdaee9dd7b11f4b |
institution | Directory Open Access Journal |
issn | 2076-3921 |
language | English |
last_indexed | 2024-03-12T06:49:33Z |
publishDate | 2019-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Antioxidants |
spelling | doaj.art-b70b7a3abf1e46ecafdaee9dd7b11f4b2023-09-03T00:23:31ZengMDPI AGAntioxidants2076-39212019-04-01849710.3390/antiox8040097antiox8040097Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and AdenocarcinomaAna Todorović0Snežana Pejić1Ljubica Gavrilović2Ivan Pavlović3Vesna Stojiljković4Nataša Popović5Snežana B. Pajović6Laboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaWe previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucidate the mechanism of the observed changes, we examined protein and mRNA levels of copper-zinc superoxide dismutase (CuZnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and transcription factor Nrf2. We also examined correlations of AOE expression with AOE activity, lipid hydroperoxides (LOOH) level, and level of Nrf2. Our results showed decreased CuZnSOD, CAT, and Nrf2 levels, and increased GPx and GR levels in hyperplasias, while in patients with adenocarcinoma, the level of CAT was decreased and GR was increased, compared to benign groups. Similar changes in mRNA levels were also detected, indicating predominantly translational control of the AOE expression. The positive correlation of enzyme expression/activity was recorded for CuZnSOD, GPx, and GR, but only among groups with benign diseases. Only GR and GPx expressions were positively correlated with LOOH. Nrf2 protein was positively correlated with mRNA levels of CuZnSOD and GR. Observed results indicate involvement of diverse redox mechanisms in etiopathogenesis of different gynecological diseases, and may improve redox-based approaches in current clinical practice.https://www.mdpi.com/2076-3921/8/4/97antioxidant enzymespolypsmyomahyperplasiaadenocarcinoma |
spellingShingle | Ana Todorović Snežana Pejić Ljubica Gavrilović Ivan Pavlović Vesna Stojiljković Nataša Popović Snežana B. Pajović Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma Antioxidants antioxidant enzymes polyps myoma hyperplasia adenocarcinoma |
title | Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma |
title_full | Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma |
title_fullStr | Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma |
title_full_unstemmed | Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma |
title_short | Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma |
title_sort | expression of antioxidant enzymes in patients with uterine polyp myoma hyperplasia and adenocarcinoma |
topic | antioxidant enzymes polyps myoma hyperplasia adenocarcinoma |
url | https://www.mdpi.com/2076-3921/8/4/97 |
work_keys_str_mv | AT anatodorovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT snezanapejic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT ljubicagavrilovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT ivanpavlovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT vesnastojiljkovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT natasapopovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma AT snezanabpajovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma |